[HTML][HTML] RDW 对初诊慢性粒细胞白血病慢性期患者TKI 治疗反应的早期预测价值
胡金花， 徐子瑶， 孙倩， 刘文洁， 洪鸣… - 南京医科大学学报(自然 …, 2022 - jnmu.njmu.edu.cn
… Higher red blood cell dis⁃ tribution width at diagnose is a simple negative prognostic factor
in chronic phase⁃chronic myeloid leukemia patients treated with tyrosine kinase inhibitors:A …
in chronic phase⁃chronic myeloid leukemia patients treated with tyrosine kinase inhibitors:A …
慢性髓性白血病衍生9 号染色体ASS 基因缺失与非缺失患者的临床特征
高冠论， 周璇， 许娜， 刘晓力， 魏婷， 李庆山 - 肿瘤防治研究, 2023 - zlfzyj.com
… characteristics of patients with chronic myeloid leukemia (CML) in chronic phase with deletion
… 2020 recommendations for treating chronic myeloid leukemia[J]. Leukemia, 2020, 34: 966-…
… 2020 recommendations for treating chronic myeloid leukemia[J]. Leukemia, 2020, 34: 966-…
[HTML][HTML] 儿童慢性髓性白血病酪氨酸激酶抑制剂停药的研究进展
郑方圆， 王淼， 张乐萍， 江倩 - Chinese Journal of Hematology, 2023 - ncbi.nlm.nih.gov
… 、改善生存质量扩大为追求无治疗缓解（treatment free remission，TFR），且有临床研究证实…
Treatment-free remission in chronic myeloid leukemia: can we identify prognostic factors?[J] …
Treatment-free remission in chronic myeloid leukemia: can we identify prognostic factors?[J] …
[HTML][HTML] 剂量优化： 慢性髓性白血病的个体化治疗策略
陈怡琳， 邹菁， 张龑莉， 黎纬明 - Chinese Journal of Hematology, 2022 - ncbi.nlm.nih.gov
… Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase
chronic myeloid leukemia. A patient-based survey on 1133 patients[J] Leuk Res. 2015;39(10):1055–…
chronic myeloid leukemia. A patient-based survey on 1133 patients[J] Leuk Res. 2015;39(10):1055–…
TGFBI 在头颈部鳞状细胞癌中的表达及其临床意义
周一静， 邹建银， 易红良… - 山东大学耳鼻喉眼 …, 2023 - ebhyxbwk.njournal.sdu.edu.cn
: 目的探索转化生长因子β 诱导基因(transforming growth faetor β indured gene, TGFBI) 在头颈
部鳞状细胞癌(head and neck souamous cell carcinoma, HNSCC) 中的表达及其临床意义. …
部鳞状细胞癌(head and neck souamous cell carcinoma, HNSCC) 中的表达及其临床意义. …
[PDF][PDF] 糖酵解参与调控楝酰胺抑制慢性粒细胞白血病细胞增殖的研究
曾玲芝， 王春林， 刘务玲， 杨奕樱， 李艳梅， 宋佳蕾 - 天然产物研究与开发, 2024 - trcw.ac.cn
… Chronic myeloid leukemia:2020 update on diagnosis,… Novel targeted therapies to overcome
imatinib mesylate resistance in chronic myeloid leukemia(CML)[J].Crit Rev Oncol Hematol,…
imatinib mesylate resistance in chronic myeloid leukemia(CML)[J].Crit Rev Oncol Hematol,…
慢性好中球性白血病/慢性好酸球性白血病
川島一郎， 桐戸敬太 - 臨床血液, 2023 - jstage.jst.go.jp
… kinase 2)融合遺伝子などを伴う好酸球増多症,非定形 型慢性骨髄性白血病(atypical chronic
myeloid leukemia, aCML),慢性骨髄単球性白血病(chronic myelomonocytic leukemia, CMML), …
myeloid leukemia, aCML),慢性骨髄単球性白血病(chronic myelomonocytic leukemia, CMML), …
人参皂苷Rg1 联合阿霉素对K562/ADR 细胞增殖及耐药的影响
唐紫云， 李敏瑞， 张成桂， 刘衡， 周玥 - 医学研究与教育, 2023 - yxyjyjy.hbu.edu.cn
… chronic myeloid leukemia (CML) and its reversal of drug resistance in K562/ ADR cells.
Methods CCK-8 assay was used to detect the effects of different concentrations of ginsenoside …
Methods CCK-8 assay was used to detect the effects of different concentrations of ginsenoside …
[HTML][HTML] 尼洛替尼一线治疗慢性髓性白血病的疗效及影响实现分子学反应的因素分析
凌云陈， 李珍， 张䶮莉， 周健， 赵慧芳… - Chinese Journal of …, 2020 - ncbi.nlm.nih.gov
… This study aimed to investigate the efficacy and safety of nilotinib as the first-line treatment
for patients with chronic myelogenous leukemia (CML) and analyze the factors affecting the …
for patients with chronic myelogenous leukemia (CML) and analyze the factors affecting the …
[HTML][HTML] 西达本胺联合吗替麦考酚酯抑制继发性急性髓系白血病细胞增殖
蔡铎， 梁思敏， 周巧， 王利 - 2022 - aammt.tmmu.edu.cn
… mofetil (MMF) on the proliferation of secondary acute myeloid leukemia (sAML) cells.
Methods Chronic myeloid leukemia blast-phase cell line K562 and myelodysplastic syndromes (…
Methods Chronic myeloid leukemia blast-phase cell line K562 and myelodysplastic syndromes (…